$Histogenics(OCGN)$ good dip to buy. Covaxin effective against 3 new mutated variant including india's double mutant. EUA and FDA on the way, once approved we will be positioned near Moderna's market cap if not Novavax. Easy storage, charging 10bucks per vax, 40% net profit deal partnership w India. Imagine the possibilities. This Friday is the day
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- 马达娃娃·2021-05-04看好ocgn吗LikeReport